These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 22037437)
1. Socio-economic modelling of rotavirus vaccination in Castilla y Leon, Spain. Pérez-Rubio A; Luquero FJ; Eiros Bouza JM; Castrodeza Sanz JJ; Bachiller Luque MR; de Lejarazu RO; Sánchez Porto A Infez Med; 2011 Sep; 19(3):166-75. PubMed ID: 22037437 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model. Patel HD; Roberts ET; Constenla DO Vaccine; 2013 Dec; 31(51):6072-8. PubMed ID: 24176497 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of childhood rotavirus vaccination in Germany. Aidelsburger P; Grabein K; Böhm K; Dietl M; Wasem J; Koch J; Ultsch B; Weidemann F; Wichmann O Vaccine; 2014 Apr; 32(17):1964-74. PubMed ID: 24561052 [TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of childhood rotavirus vaccination in Taiwan. Wu CL; Yang YC; Huang LM; Chen KT Vaccine; 2009 Mar; 27(10):1492-9. PubMed ID: 19186200 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland. Tilson L; Jit M; Schmitz S; Walsh C; Garvey P; McKeown P; Barry M Vaccine; 2011 Oct; 29(43):7463-73. PubMed ID: 21821085 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option. Cui S; Tobe RG; Mo X; Liu X; Xu L; Li S BMC Infect Dis; 2016 Nov; 16(1):677. PubMed ID: 27846803 [TBL] [Abstract][Full Text] [Related]
9. Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination. Jit M; Edmunds WJ Vaccine; 2007 May; 25(20):3971-9. PubMed ID: 17400341 [TBL] [Abstract][Full Text] [Related]
10. Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization schedule. Milne RJ; Grimwood K Value Health; 2009 Sep; 12(6):888-98. PubMed ID: 19490550 [TBL] [Abstract][Full Text] [Related]
11. Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain. Orrico-Sanchez A; López-Lacort M; Pérez-Vilar S; Díez-Domingo J BMC Infect Dis; 2017 Apr; 17(1):267. PubMed ID: 28399824 [TBL] [Abstract][Full Text] [Related]
12. Rotavirus vaccine: a cost effective control measure for India. Kumar A; Goel MK; Jain RB; Khanna P; Vibha V Hum Vaccin Immunother; 2012 Apr; 8(4):501-4. PubMed ID: 23071989 [TBL] [Abstract][Full Text] [Related]
13. Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq. Weycker D; Sofrygin O; Kemner JE; Pelton SI; Oster G Vaccine; 2009 Aug; 27(36):4930-7. PubMed ID: 19555715 [TBL] [Abstract][Full Text] [Related]
14. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries. Tu HA; Rozenbaum MH; Coyte PC; Li SC; Woerdenbag HJ; Postma MJ Vaccine; 2012 Feb; 30(8):1521-8. PubMed ID: 22119590 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related mortality: A South Korean study. Lee H; Park SY; Clark A; Debellut F; Pecenka C; Kim DS; Kim HM; Kim JH; Cho H; Kim AY; Lee M; Jung SY; Seong BL; Kang HY Vaccine; 2019 Aug; 37(35):4987-4995. PubMed ID: 31326252 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan. Itzler RF; Chen PY; Lac C; El Khoury AC; Cook JR J Med Econ; 2011; 14(6):748-58. PubMed ID: 21919673 [TBL] [Abstract][Full Text] [Related]
17. Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries. Plosker GL Pharmacoeconomics; 2011 May; 29(5):439-54. PubMed ID: 21504245 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in Belgium. Bilcke J; Van Damme P; Beutels P Med Decis Making; 2009; 29(1):33-50. PubMed ID: 18948433 [TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness of a pentavalent rotavirus vaccine in Oman. Al Awaidy ST; Gebremeskel BG; Al Obeidani I; Al Baqlani S; Haddadin W; O'Brien MA BMC Infect Dis; 2014 Jun; 14():334. PubMed ID: 24941946 [TBL] [Abstract][Full Text] [Related]
20. Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel. Chodick G; Waisbourd-Zinman O; Shalev V; Kokia E; Rabinovich M; Ashkenazi S Eur J Public Health; 2009 Jun; 19(3):254-9. PubMed ID: 19221026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]